Cannabis
Radient Announces Update on Trading Reinstatement
Edmonton, Alberta–(Newsfile Corp. – April 3, 2023) – Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF) (“Radient” or the “Company“) is pleased to announce that the Company has applied to the TSX Venture Exchange (the “TSXV“) to reinstate trading of its common shares and is preparing responses to the TSXV’s enquiries and compiling the requisite materials.
As previously announced on March 30, 2023, the Alberta Securities Commission granted Radient a revocation order respecting a failure-to-file cease trade order (“FFCTO“) that has been in effect since March 7, 2023. The revocation order also evidences the decision of the Ontario Securities Commission. The issuance of the revocation order follows the filing by Radient of its interim financial statements for the nine-month period ended December 31, 2022, and the related Management’s Discussion and Analysis and Certifications on March 22, 2023. On March 8, 2023, following the issuance of the FFCTO, the TSXV suspended trading of the Company’s common shares.
The Company would like to thank its shareholders and supporters for their patience at this time and confirms that it will endeavour to issue regular press releases to keep investors apprised of the situation, including of any anticipated trading resumption timeline.
About Radient
Radient is a commercial manufacturer of diverse, novel and high-quality cannabis extracts and packaged products. Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. Please visit www.radientinc.com for more information.
For more information, please contact:
Steven Splinter, CEO & Director
[email protected]
Ph: 780 465 1318
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161168
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis6 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE6 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Humboldt6 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis6 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis4 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III